AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Anemia Management for MDS
This chapter explores the complexities of managing anemia in myelodysplastic syndromes (MDS), emphasizing the need for more aggressive treatment strategies and proper dose escalation of erythropoiesis-stimulating agents (ESAs). It highlights the importance of patient quality of life and recent advancements in combination therapies, alongside discussing the significance of dual endpoints in treatment evaluations. Through a focus on emerging therapies and practical considerations, the chapter advocates for a reevaluation of treatment protocols to optimize patient outcomes.